As of April 22, 2025, GamaLife (BTRVB.LS) has a market cap of $5.67 billion USD. According to our data, GamaLife is ranked No.2406 in global market value.
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() AbbVie
ABBV
|
$311.86 B |
5.102 B
|
![]() USA
|
![]() Amgen
AMGN
|
$151.18 B |
2.124 B
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.17 B |
0.596 B
|
![]() USA
|
![]() Eli Lilly
LLY
|
$759.54 B |
19.840 B
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$380.42 B |
1.328 B
|
![]() USA
|
![]() Merck
MRK
|
$197.89 B |
0.381 B
|
![]() USA
|
![]() Novartis
NVS
|
$221.14 B |
1.573 B
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$127.76 B |
0.558 B
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$63.95 B |
1.249 B
|
![]() USA
|
![]() Sanofi
SNY
|
$128.24 B |
1.871 B
|
![]() France
|
![]() Gilead Sciences
GILD
|
$132.09 B |
0.265 B
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$74.36 B |
-0.002 M
|
![]() UK
|
![]() AstraZeneca
AZN
|
$211.08 B |
0.256 B
|
![]() UK
|
![]() Biogen
BIIB
|
$17.65 B |
0.315 B
|
![]() USA
|
Market Cap | = | BTRVB.LS Stock Price | * | BTRVB.LS Shares Outstanding |
= | $113.30 | * | 50.00 M | |
= | $5.67 B |